	Clinical significance of TP53 mutations in patients with acute myeloid leukemia: the HM-SCREEN-JAPAN 01/02 study. Int J Hematol Ogasawara F, Minami Y, Chi S, Ueda T, Fukushima K, Kojima K. PMID: 41915141 [PubMed - as supplied by publisher]
	Relationships Between Clinician-Patient Communication and the Quality of Life of Patients With Leukaemia: A Prospective Cross-Sectional Global Study. Cancer Control Nier S, Poots AJ, Gunn S, Oliva EN, Ionova T, Salek S. PMID: 41914705 [PubMed - indexed for MEDLINE]
	Incidence and Risk Factors of Serious Osteonecrosis in Pediatric Acute Lymphoblastic Leukemia: AÂ CYP-C Population-Based Study. Pediatr Blood Cancer de Villiers N, Éthier C, Laverdière C, Alos N, Tran TH, Pelland-Marcotte MC. PMID: 41914452 [PubMed - as supplied by publisher]
	Hypomethylating agents plus venetoclax in younger acute myeloid leukemia: Meta-analysis of a shifting treatment paradigm. Cancer Perrone S, De Fazio L, Monachetti S, Molica M. PMID: 41914434 [PubMed - indexed for MEDLINE]
	Potential Application of CAR-NK Cells as an Ex Vivo Therapy for T-cell-related Diseases. Front Biosci (Landmark Ed) Kwon D, Kang KS. PMID: 41914298 [PubMed - indexed for MEDLINE]
	Navigating the Landscape of Antibody Drug Conjugates: Current Trends and Future Research Prospects in Acute Myeloid Leukemia. Front Biosci (Elite Ed) Shah AC, Saluja SG, Trivedi JD, Mehta SH, Patel R, Chorawala MR, Dudhat K, Prajapati BG. PMID: 41914165 [PubMed - indexed for MEDLINE]
	Exploring mixed phenotype acute leukemia: Clinical, immunophenotypic, cytogenetic, and prognostic insights from a tertiary care center. Indian J Pathol Microbiol Sarjana, Jasmita, Agarwal M, Ganesh V, Mahapatra M. PMID: 41913419 [PubMed - indexed for MEDLINE]
	Patients' and healthcare providers' views regarding dose reduction of tyrosine kinase inhibitors in chronic myeloid leukemia: a qualitative study. Oncologist Lokhorst DN, van den Bemt BJF, Smit Y, Hermens RPMG, Blijlevens NMA, Bekker CL. PMID: 41913063 [PubMed - as supplied by publisher]
	HSR26-241: Prophylactic G-CSF (Granulocyte Colony-Stimulating Factor) in AML (Acute Myeloid Leukemia) Induction: A Meta-Analysis Dispelling Relapse Concerns and Reinforcing Supportive Benefit. J Natl Compr Canc Netw Sharma A, Sharma A, Daid SS, Meseeha M, Poulose J. PMID: 41911849 [PubMed - in process]
	HSR26-227: Post-Allogenic Hematopoietic Stem Cell Transplant (Allo-HSCT), Hypomethylating-Agent Maintenance Improves Survival Without Increasing GVHD (Graft Versus Host Disease) in AML/MDS (Acute Myeloid Leukemia/Myelodysplastic Syndrome): Updated Systematic Review and Meta-Analysis. J Natl Compr Canc Netw Sharma A, Sharma A, Daid SS, Meseeha M, Poulose J. PMID: 41911838 [PubMed - in process]
	HSR26-228: BTK Inhibitor (Bruton Tyrosine Kinase Inhibitor) Plus Anti-CD20 Antibody Therapy Surpasses CIT (Chemoimmunotherapy) in Frontline CLL (Chronic Lymphocytic Leukemia) With Obinutuzumab Drives Deeper Remissions: A Meta-Analysis of Randomized Controlled Trials. J Natl Compr Canc Netw Sharma A, Daid SS, Sharma A, Meseeha M, Poulose J. PMID: 41911756 [PubMed - in process]
	CLO26-106: From Vasculitis to NK/T-Cell Lymphoma: A Complex Diagnosis in a Patient With a Midline Tumor and Positive ANCA. J Natl Compr Canc Netw Hernández I, Vargas LP, León JMM, Ballesteros-García MC, Bacca J, Ferro JD, Dorado L, Santoyo-Sarmiento N. PMID: 41911732 [PubMed - in process]
	Transforming Acute Myeloid Leukemia Care Through Precision Medicine: Integrating Genomic Profiling, Measurable Residual Disease, and Targeted Therapies. Oncology Al-Shibly R, Benkhadra M, Yassin MA. PMID: 41911081 [PubMed - as supplied by publisher]
	LM-101, an anti-SIRPÎ± antibody, in patients with relapsed/refractory lymphoma and advanced head and neck cancer: an open-label, multicenter, phase 1 trial. Clin Cancer Res Cai J, Zhao B, Ji D, Zhou F, Bai S, Fang X, Nie M, Bai B, Zhang Y, Li J, Li H, Li Y, Fei D, Qin X, Qin C, Zhao S, Xia Y, Cai Q. PMID: 41910591 [PubMed - as supplied by publisher]
	Pharmacokinetics, efficacy, and safety of arsenic formulations in acute promyelocytic leukemia treatment. Expert Rev Clin Pharmacol Marvin-Peek J, Jen WY, Ravandi F. PMID: 41910474 [PubMed - as supplied by publisher]
	Aggressive extramedullary acute myeloid leukaemia masquerading as dental infection with rare t(10:11) translocation and subsequent relapse as leukaemia cutis. J Cancer Res Ther Pustake M, Kalas M, Valles-Gamez R, Eysha M, Didia SC, Gaur S. PMID: 41910305 [PubMed - indexed for MEDLINE]
	A phase I open label study of fostamatinib, a SYK inhibitor, in patients with lower-risk myelodysplastic syndrome and chronic myelomonocytic leukemia. Leuk Lymphoma Croden J, Garcia-Manero G, Chien K, DiNardo C, Borthakur G, Hammond D, Bose P, Short N, Romero L, Shneider H, Hatfield M, Pierce S, Huang X, Hwang H, Montalban-Bravo G. PMID: 41909958 [PubMed - as supplied by publisher]
	Dupilumab and cutaneous T-cell lymphoma: A retrospective cohort study. JAAD Int Baghdasarian S, Al-Saedi O, Cuomo RE. PMID: 41907483 [PubMed]
	Allogeneic transplant outcomes in T-cell prolymphocytic leukemia: a single-center retrospective study. Leuk Lymphoma Merrill M, Kim HT, Kelkar AH, Panaro K, Tamada R, Au C, Singh S, Vicks A, Jain S, Ritz J, Ho VT, Jacobsen E. PMID: 41906811 [PubMed - as supplied by publisher]
	Nationwide Incidence, Treatment Pattern, and Prognosis of Primary CNS Lymphoma in Taiwan, 2012-2020: A Retrospective Cohort Study. Cancer Med Hsiao FY, Lin HY, Chen HM, Hsu WH, Ko BS. PMID: 41906256 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 166857

Page 1 of 8343



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy